BIOLASE (NASDAQ:BIOL) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a research note issued to investors on Wednesday. The brokerage issued a sell rating on the medical technology company’s stock.

BIOLASE Price Performance

Shares of BIOL stock opened at $0.01 on Wednesday. The firm has a market capitalization of $273,937.40, a PE ratio of 0.00 and a beta of 0.67. The company has a 50 day moving average price of $0.01 and a 200-day moving average price of $0.01. BIOLASE has a 52 week low of $0.02 and a 52 week high of $1.94.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.